Quality of Life in Asthmatic Children at School Age
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01475916|
Recruitment Status : Unknown
Verified November 2011 by University Hospital, Clermont-Ferrand.
Recruitment status was: Not yet recruiting
First Posted : November 22, 2011
Last Update Posted : November 22, 2011
Asthma is the most common chronic disease in childhood . The advantage of an educational program in a global strategy of care has been established in asthma (decrease of nocturnal asthma, absence from work and school) [2, 3]. Therapeutic education of the patient permits the reduction of the rate of hospitalization, of the rate of emergencies visits and non-programmed visits. .
The WHO defines quality of life as an individual's perception of its place in existence, in the context of culture and value system in which he lives, in relation to its objectives, expectations, standards and concerns . The basic point of this concept is the notion of perception, emphasizing the perspective of the person. It is a broad concept affected in a complex way by the subject's physical health, psychological state, level of independence, social relationships, and its relations with its environment. In the field of health, analyzing the quality of life includes objective aspects (living conditions, functional health) and subjective aspects (satisfaction, happiness, well-being) that allow to understand the situation of people in whole.
As defined by the WHO-Europe report published in 1996 , the therapeutic education aims to help patients acquire or maintain the competencies they need to best manage their lives with a chronic disease.
It is entirely part of the management of the patient. It includes organized activities designed to make patients aware and informed of their disease, of care organization and hospital procedures, and the behaviors related to health and disease. This is to help them and their families understand their illness and treatment, to work together and to gain autonomy from their disease in order to help maintain and improve their quality of life .
However, studies demonstrating the effectiveness of therapeutic patient education are still very few, especially in children. The need for prospective studies including the evaluation of the impact on quality of life was highlighted in a recent Cochrane meta-analysis . It seems interesting for the authors to assess the improvement of the quality of life after educational sessions in children at school-age.
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Behavioral: Educational program: consultation with paediatric pulmonologist||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Quality of Life in Asthmatic Children at School Age : Influence of Therapeutic Education|
|Study Start Date :||December 2011|
|Estimated Primary Completion Date :||April 2012|
|Estimated Study Completion Date :||October 2012|
Behavioral: Educational program: consultation with paediatric pulmonologist
- AUQUEI questionnaire (Asthma Caregiver's Quality of Life) [ Time Frame: 3 or 4 months after the diagnosis of asthma ]
- Clinical control of asthma measured by the Asthma Control Test [ Time Frame: 3 or 4 months after the diagnosis of asthma ]
- Frequence and severity of the exacerbations [ Time Frame: 3 or 4 months after the diagnosis of asthma ]
- assessment of pulmonary function by spirometry [ Time Frame: 3 or 4 months after the diagnosis of asthma ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01475916
|Contact: Patrick LACARIN||04 73 75 11 email@example.com|
|Principal Investigator:||André LABBE, Md, PhD||University Hospital, Clermont-Ferrand|